Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: Results from a prospective community oncology study Academic Article uri icon

Overview

MeSH Major

  • Erythropoietin
  • Hematinics
  • Hemoglobin A
  • Neoplasms
  • Quality of Life

abstract

  • Epoetin alfa appears to have a beneficial impact on patient-reported functional capacity and quality of life in patients with cancer who received chemotherapy independent of tumor response. Concordantly, epoetin alfa appeared to increase hemoglobin levels and decrease transfusion use. Patients responded across all tumor types. The results suggest that epoetin alfa effectively improves functional outcomes in patients with cancer who receive chemotherapy.

publication date

  • October 1998

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 9779721

Additional Document Info

start page

  • 3412

end page

  • 25

volume

  • 16

number

  • 10